Berner K, Hernes E, Kvassheim M, Revheim ME, et al. First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted (212)Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer. J Nucl Med 2025 Mar 13:jnumed.124.269299. doi: 10.2967/jnumed.124.269299.
PMID: 40081958